feedburner
Enter your email address:

Delivered by FeedBurner

Choose Your Stocks


Reyoung Pharmaceutical Holdings reports 2QFY09 Results (14 Aug 09)

Labels:

  • Revenue: +6.4% (2Q09), +7.9% (1H09)
  • Net Profit: -25.4% (2Q09), -12.4% (1H09)
  • Outlook: The Group is continuously operating in a very keen and competitive environment for our product segments.
  • To maintain its competitiveness, the Group continuously upgrade its production facilities to meet the increase in market demand and meet its customers’ needs.
  • The Group also exercise tighter control on its operating costs and strive to offer its products at the most competitive price for the best quality.
  • For its pharmaceutical division, the construction work for the major part of its new production facilityhas been completed and production has commenced at the new facility.
  • For personal hygiene products, the Group continues to face very keen competition from foreign brands.
  • This keen competition from foreign brands has significantly affected its sales volume.
  • As a strategy to increase its sales volume, the Group has expanded its sales network in other parts of the PRC.
  • Barring unforeseeable circumstances, the Group expects to be profitable in 2009.

FINANCIAL RECORDS

Revenue (RMB '000)

FY 1Q 2Q 3Q 4Q Total

2009 235,927 226,294
2008 215,612 212,726 199,867 186,216 814,421
2007 163,222 214,124 183,547 162,721 723,673
2006 168,045 171,998 163,739 153,163 656,945
2005 137,463 137,136 158,825 147,499 580,923
2004 NA NA NA NA 217,445
-----------------------------------------------------------
Earnings (RMB '000)

FY 1Q 2Q 3Q 4Q Total

2009 12,966 10,128
2008 12,769 13,583 12,216 2,306 40,874
2007 19,902 25,670 19,804 10,412 75,788
2006 20,774 26,428 19,794 4,683 71,679
2005 17,639 20,939 19,015 17,168 74,762
2004 NA NA NA NA 54,156
-----------------------------------------------------------
Dividends

FY Interim Final Special (RMB)

2009 NA
2008 NA NA NA
2007 NA 0.046 NA
2006 NA 0.045 NA
2005 NA 0.015 NA
-----------------------------------------------------------
Bonus / Rights / Stock Split

Date Type Details
NA
-----------------------------------------------------------
Share Data (RMB)

NAV = $1.58
EPS = $0.0721 (6M FY09)
No of Shares = 313,830,000
-----------------------------------------------------------

ANALYSTS' TARGET PRICES

Broker Recommendation Target Price Date

NA



0 Comments:

Post a Comment